Resorbable vs Non-resorbable Bone Substitute at Immediate Post-extractive Single Implants (NCT07047131) | Clinical Trial Compass
Active — Not RecruitingPhase 3
Resorbable vs Non-resorbable Bone Substitute at Immediate Post-extractive Single Implants
Spain50 participantsStarted 2018-12-18
Plain-language summary
This study compares two bone graft materials used when placing a dental implant right after tooth removal. One graft fully dissolves (GTO®), the other only partly (Apatos®).
The goal is to see which one better preserves bone and improves appearance around the implant.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Any patient requiring at least one single immediate post-extractive implant.
* At least 18 year old, able to understand and to sign an informed consent
* There must be sufficient bone to allow the placement of at least a 3.5 mm diameter and 8.5 mm long implant.
* After tooth extraction there must be a potential gap of at least 2 mm from the buccal inner bone plate and the implant surface.
Exclusion Criteria:
* General contraindications to implant surgery.
* Immunosuppressed or immunocompromised patients.
* Patients irradiated in the head and/or neck.
* Uncontrolled diabetes.
* Pregnancy or lactation.
* Active periodontal disease
* Poor oral hygiene and motivation.
* Addiction to alcohol or drugs.
* Psychiatric problems and/or unrealistic expectations
* Patients with an acute infection (abscess) in the site intended for implant placement.
* Patients unable to commit to a 5-year follow-up.
* Patients treated or under treatment with intravenous amino-bisphosphonates.
* patients referred only for implant placement if follow-ups cannot be done at treatment centre.
* Patients participating in other studies, if the present protocol could not be fully adhered to. In case of doubts please contact the study coordinator.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Changes in peri-implant bone volumes
Timeframe: From enrollment to 5 years after implant loading